Dated 20th May 2026 with respect to financial results for the quarter and year ended 31st March 2026
As filed · Press Release
EarningsNotablemateriality 70 out of 100
What happened
Factdated 20th May 2026 with respect to financial results for the quarter and year ended 31st March 2026.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnEarlierQ1 FY27
FY26-27 Guidance Exports Contribution 25%-30%
NowQ1 FY27
However, we will be able to -- having the current scenario, we think that we may cross that number.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe earlier statement provided a specific guidance of 25%-30% for exports contribution, while the current statement suggests uncertainty and implies that the previous target may not be met.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- FY26-27 Guidance EBITDA Margin 14%-15% (management committed by FY27)
- FY26-27 Guidance Revenue Growth 15%-20% (management committed by FY27)
Evidence
- IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 20, 2026, titled "Press Release Financial Results for the quarter and year ended 31st March 2026".(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%